These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 4037242)
1. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children. Hanada T; Abe T; Takita H Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242 [TBL] [Abstract][Full Text] [Related]
2. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children. Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child. Favier R; Deschamps A; Belhocine R; Ankri A; Costil J; de Moerloose P Hematol Cell Ther; 1998 Apr; 40(2):67-70. PubMed ID: 9615249 [TBL] [Abstract][Full Text] [Related]
4. [Disseminated intravascular coagulation in children. Therapeutic problems]. Fiori GM; Murgia G; Targhetta R; Putzolu G; Biddau P Pediatr Med Chir; 1989; 11(5):491-4. PubMed ID: 2698466 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection]. Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177 [TBL] [Abstract][Full Text] [Related]
6. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits]. Gómez C; Páramo JA; Rocha E Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238 [TBL] [Abstract][Full Text] [Related]
7. Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases. Hatae Y; Takeda T; Hattori T; Nakadate H; Nishi M Jpn J Clin Oncol; 1985 Sep; 15(3):483-8. PubMed ID: 4057631 [TBL] [Abstract][Full Text] [Related]
8. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)]. Takahashi K Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410 [No Abstract] [Full Text] [Related]
9. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections. Mertens R; Peschgens T; Granzen B; Heimann G Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813 [TBL] [Abstract][Full Text] [Related]
10. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness. Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. Rodríguez Gómez M; López Fernández MF; Batlle J Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380 [TBL] [Abstract][Full Text] [Related]
13. Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study. van Beek EJ; von der Möhlen MA; ten Cate JW; Brandjes DP; Büller HR Neth J Med; 1994 Nov; 45(5):206-10. PubMed ID: 7830846 [TBL] [Abstract][Full Text] [Related]
14. Treatment of DIC with antithrombin III concentrates. Sakata Y; Yoshida N; Matsuda M; Aoki N Bibl Haematol; 1983; (49):307-16. PubMed ID: 6667252 [TBL] [Abstract][Full Text] [Related]
15. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation]. Sobczyk J; Swietliński J; Podleśny-Owsińska T Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947 [No Abstract] [Full Text] [Related]
16. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy]. von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907 [TBL] [Abstract][Full Text] [Related]
17. Endotoxin-induced intravascular coagulation (DIC) and its therapy. Prager RL; Dunn EL; Kirsh MM; Penner JA Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581 [TBL] [Abstract][Full Text] [Related]
18. [Use of antithrombin III concentrates]. Vinazzer H Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532 [TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats. Bahrami S; Paul E; Redl H; Schlag G Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743 [No Abstract] [Full Text] [Related] [Next] [New Search]